Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7401

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0904-7401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (508e310e 067a 4f95 869a E1da49aabe94 00)

This text provides information regarding Cyclobenzaprine Hydrochloride Tablets, USP in a unit dose package containing 100 tablets. The typical adult dosage is one tablet (10 mg) three times a day. It includes storage instructions, precautionary measures, and warnings. The packaging is not child-resistant and is meant for institutional use only. The product is dispensed in a well-closed container, and it is advised to keep it out of children's reach. The manufacturer is Major Pharmaceuticals and the product is made in India.*

FDA Label Image

Carton Label (508e310e 067a 4f95 869a E1da49aabe94 01)

This text provides information on Cyclobenzaprine Hydrochloride Tablets, USP in a unit dose package containing 30 tablets. Each film-coated tablet contains Cyclobenzaprine hydrochloride USP § mg, with the usual adult dosage being one tablet (5 mg) three times a day. It includes instructions for storage, precautions, and warnings. The drug is intended for individual use and should be kept out of the reach of children. The packaging is identified with NDC 0904-7400-04.*

FDA Label Image

Chemical Structure (Cyclobenz Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.